Why a non-substitutable generic? Because Lovenox is a complex biological drug, Viehbacher said, and regulators will have to carefully study any copies to make sure they're safe and effective. And ...

Sanofi-Aventis has received approval from US regulators for expanded use of its blockbuster anticoagulant Lovenox as a treatment for severe heart attacks.

Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the kidneys.

Sanofi-Aventis is suing FDA, claiming the agency acted inconsistently and unlawfully in approving a generic version of its anticoagulant Lovenox. The approval of the generic, developed by Momenta ...

Doctors in Europe can continue to use Sanofi-Aventis SA's <SASY.PA> heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European Medicines ...

The maker of a popular brand-name medicine used to prevent blood clots is seeking a court order to prevent sales of a generic version approved by the FDA last week.

> Sanofi-Aventis received FDA approval to market the blood thinner Lovenox for acute ST-segment elevation myocardial infarction, a severe type of heart attack. Report > AVANT Immunotherapeutics ...

The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding and ...